Neuroleptic malignant syndrome: a neuroimmunologic hypothesis
- Successful treatment of a complicated case of neuroleptic malignant syndrome. Lappa, A.; Podestà, M.; Capelli, O.; Castagna, A.; Di Placido, G.; Alampi, D.; Semeraro, F. // Intensive Care Medicine;Jul2002, Vol. 28 Issue 7, p976
Neuroleptic malignant syndrome (NMS) is a life-threatening reaction often related to neuroleptic drugs, characterized by rigidity, hyperthermia, altered consciousness, and fluctuating blood pressure. We present a case of NMS that followed a doubled oral dose of a drug compound: tranylcypromine...
- Neuroleptic malignant syndrome following cardiac surgery: successful treatment with dantrolene. Mieno, Shigetoshi; Asada, Kunio; Horimoto, Hitoshi; Sasaki, Shinjiro // European Journal of Cardio-Thoracic Surgery;Sep2003, Vol. 24 Issue 3, p458
Neuroleptic malignant syndrome (NMS) is a rare idiosyncratic reaction to neuroleptic drugs, which is potentially fatal. It has been occasionally reported that NMS occurs subsequently after surgery. We report a case of a 53-year-old male patient who developed NMS following cardiac surgery due to...
- Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem. Poyurovsky, Michael; Weizman, Abraham // British Journal of Psychiatry;Jul2001, Vol. 179, p4
The article discusses the serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia (NIA). According to the author, the new approach is characterized by a subjective sense of inner restlessness and objective fidgety movements. NIA is a major extrapyramidal side-effect of...
- Incipient Neuroleptic Malignant Syndrome? Velamoor, V. A.; Fernando, M. L. D.; Williamson, P. // British Journal of Psychiatry;Apr90, Vol. 156, p581
Recognising confusion as an antecedent to NMS may help abort the full-blown syndrome. Two such cases are reported, along with a third.
- Neuroleptic Malignant Syndrome Secondary to Loxapine. Chong, L.S.; Abbott, P.M. // British Journal of Psychiatry;Oct91, Vol. 159, p572
Loxapine was introduced to the British market two years ago although it has been used in North America for eight years. We report the first probable case of neuroleptic malignant syndrome (NMS) secondary to loxapine in Britain. Two previous cases have been reported in North America...
- Neuroleptic Malignant Syndrome in Striatonigral Degeneration. Gibb, W. R. G. // British Journal of Psychiatry;Aug88, Vol. 153, p254
A case of probable neuroleptic malignant syndrome (NMSI complicating L-dopa withdrawal in striatonigral degeneration is described. This case suggests that the hyperthermia of NMS is due to peripheral heat production associated with severe muscular rigidity secondary to withdrawal of striatal...
- Paliperidone. // Reactions Weekly;1/19/2008, Issue 1185, p24
The article describes the case of possible neuroleptic malignant syndrome (NMS) associated with paliperidone in a 63-year-old woman with chronic paranoid schizophrenia. The patient developed NMS during treatment with paliperidone. Six days following the initiation of paliperidone treatment, the...
- Neuroleptic Malignant Syndrome with Trifluperidol. Singh, S. P.; Giridhar, C.; Avasthi, A. // British Journal of Psychiatry;Oct89, Vol. 155, p561
In a case of NMS subsequent to administration of trifluperidol to a young man, the patient responded remarkably quickly to bromocriptine. The authors point out the deficiencies in the diagnostic criteria, which need further refinement for a better understanding of the syndrome.
- Neuroleptic Malignant Syndrome in a Case of Post-Partum Psychosis. Price, D.K.; Turnbull, G.J.; Gregory, R.P.; Stevens, D.G. // British Journal of Psychiatry;Dec89, Vol. 155, p849
A 27-year-old woman with a post-partum psychosis developed NMS which proved difficult to diagnose because of the organic features of the presenting illness. Possible contributory factors to the development of NMS included exhaustion, a non-specific viral illness, and rapid loading with haloperidol.